Clinical Trial: Predictive value of early expansion of myeloid-derived suppressor cells and T-cell exhaustion for 28-day prognosis in patients with severe pulmonary tuberculosis (China)

China, Oct. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Predictive value of early expansion of myeloid-derived suppressor cells and T-cell exhaustion for 28-day prognosis in patients with severe pulmonary tuberculosis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134434

Registration Time: 2026/10/14

Type: Observational study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347145

Published by HT Digital Content Services with permission from Health Daily Digest....